Cycle health, decoded.

Editorial summary.

A menstrual cycle is the most reliable monthly read of women's-health status the body offers, and the most underused. The standard U.S. clinical visit treats the period as a yes/no question — do you bleed regularly, any pain — and rarely goes further. The cycle itself, read attentively across cycle length, ovulation signs, flow, PMS pattern and mid-cycle symptoms, is closer to a recurring report card on hormonal, thyroid and nutritional status than any single annual lab draw will ever be.

Two ideas worth holding from the start. First: a "regular" cycle is not necessarily a "healthy" cycle. You can have a textbook 28-day cycle that is anovulatory (no egg released), or that has a luteal phase too short to support implantation, or that masks an underlying issue like thyroid dysfunction or hyperprolactinemia. Regularity is part of the picture, not the picture. Second: when you draw a hormone matters as much as which hormone you draw. A progesterone level on day three of the cycle tells you essentially nothing useful. The same value drawn on day twenty-one of a 28-day cycle tells you whether you ovulated.

This page walks through what a typical cycle could look like, what each phase is doing, the biomarkers worth measuring, and the cycle-day timing that makes the measurements meaningful. If you want a shortcut to the relevant testing options, the Heme Quiz routes you. Otherwise, read on.

What a menstrual cycle actually is.

A cycle is conventionally counted from day one of menstrual bleeding to day one of the next bleed. The average cycle length is roughly 28 days, but anything between 21 and 35 days falls within what most clinicians consider a typical range. Cycle length tends to be slightly longer in the teens and twenties, shorter in the late thirties and forties, and more variable on either end of reproductive life. Your own cycle is your reference point — month-to-month consistency, more than alignment with a textbook 28-day pattern, is what matters most.

Each cycle has two distinct phases divided by ovulation. The follicular phase runs from day one to ovulation — typically around day fourteen in a 28-day cycle, but later in longer cycles. Estrogen rises through this phase as a follicle develops. FSH (follicle-stimulating hormone) drives that development; LH (luteinizing hormone) holds steady until a surge near the end of the phase triggers ovulation. The endometrial lining thickens. Cervical mucus shifts to a clearer, stretchier "egg-white" consistency in the days approaching ovulation — a sign that estrogen is doing its job.

The luteal phase runs from ovulation to the next period — and unlike the follicular phase, the luteal phase tends to be more consistent in length, roughly twelve to fourteen days in most women. After ovulation, the empty follicle becomes the corpus luteum, which produces progesterone. Progesterone stabilises the lining, raises basal body temperature by roughly half a degree Fahrenheit, calms the nervous system (it's a precursor to GABA-active metabolites), and prepares the body for possible pregnancy. If pregnancy doesn't happen, the corpus luteum dissolves, progesterone falls, and the lining sheds — that's the period.

The reason cycle-day timing matters so much for testing: hormones move dramatically across these phases. Estradiol at the start of the cycle is low; by ovulation it has roughly tripled; in the luteal phase it sits at an intermediate level. Progesterone is essentially absent in the follicular phase and only rises after ovulation. FSH is highest in early follicular phase. LH spikes once, briefly, around ovulation. A meaningful interpretation of any of these markers depends on knowing where in the cycle the blood was drawn. Day three and day twenty-one are the two days that get cited most often in women's-health testing — for good reason.

Common signs and patterns worth tracking.

These are observable features of the cycle that, taken together, give you a useful read on hormonal function — often before bloodwork is necessary. The patterns below are not diagnostic; they're informative, and worth tracking for a few months before any clinical conversation.

• —Cycle length and consistency. Cycles consistently shorter than 21 days or longer than 35 days, or that vary by more than seven days month to month, are worth raising. Bleeding more than once in a 21-day window is its own pattern.
• —Ovulation signs. Stretchy egg-white cervical mucus mid-cycle. A roughly half-degree rise in basal body temperature that holds for about ten to fourteen days. A positive ovulation predictor kit. Absence of all three across multiple cycles suggests anovulation may be worth investigating.
• —Flow. Period length of three to seven days. Soaking a pad or tampon roughly every three to four hours during heaviest day or two. Periods soaking through every hour for several consecutive hours, lasting longer than seven days, or producing large clots fall on the heavy end and warrant their own conversation — covered in detail in Heavy periods and iron.
• —PMS pattern. Some shift in mood, energy and appetite in the week before a period is universal. Symptoms that disrupt work, relationships or daily function — particularly severe mood, panic, or rage that recede within a day or two of bleeding — are the pattern of premenstrual dysphoric disorder (PMDD), and warrant a clinical conversation.
• —Mid-cycle symptoms. Mild one-sided pain around ovulation ("mittelschmerz") is common and benign. Severe pain, recurring on the same side, or bleeding mid-cycle every month, is not — and is worth investigating with imaging and labs.
• —Pain. Period pain that responds reasonably to over-the-counter analgesia is generally tolerable. Pain that requires staying home from work, prescription medication, or that has been getting steadily worse year over year is the pattern of conditions like endometriosis or adenomyosis — both badly underdiagnosed and worth a referral.

Tracking these features across three to six cycles — with any of the cycle apps available, or a simple notebook — gives you and any clinician a far more useful starting point than "my cycle is normal-ish, I think." It is one of the highest-yield investments in women's-health self-knowledge available.

"A regular cycle isn't necessarily a healthy cycle. Regularity is one signal among several — not the answer in itself."

The biomarkers worth knowing — and when to draw them.

The timing column matters as much as the marker column. For most cycle-related testing, the two reference days are day 3 (early follicular phase, with day 1 being the first day of full bleeding) and day 21 of a 28-day cycle (mid-luteal, roughly seven days after suspected ovulation). For longer cycles, day 21 should shift later — the rule is "seven days after ovulation," not "day 21 calendar-wise."

Three additional markers worth running on any women's-health workup that includes cycle questions — these are not cycle-day dependent: ferritin (heavy or even normal-volume periods deplete iron faster than most women realise), vitamin D (low across U.S. women, influences mood and immune function), and a basic metabolic panel with HbA1c (insulin resistance is a meaningful contributor to PCOS-spectrum cycle issues).

If your current provider isn't comfortable with cycle-day-timed testing, a referral to an OB-GYN or a reproductive endocrinologist is reasonable — particularly if you're trying to conceive or have had cycle issues for more than six months.

What may help.

None of these replace clinical conversations, particularly if your cycle has been irregular, painful or absent. The honest summary of categories that frequently come up in women's-health practice, with the strong caveat that what's appropriate depends entirely on what's actually driving your pattern.

6.1 Tracking the cycle systematically

Three to six months of structured tracking — cycle length, ovulation signs, flow, pain, mood, sleep, energy — is the highest-yield, lowest-cost intervention in cycle health. It transforms what a clinician can work with. Apps like Natural Cycles, Read Your Body and others handle the logistics; a paper notebook does too. The point is consistency, not the platform.

6.2 Replacing measurable depletions first

Where labs identify gaps — low ferritin, low vitamin D, low B12, suboptimal thyroid — replacing them before layering on more interventions tends to be the higher-yield path. Iron in particular can shift cycle symptoms, energy and mood materially. Don't supplement iron without testing; do measure ferritin before assuming it's fine.

6.3 Resistance training, protein and sleep

The trifecta that underpins everything else. Resistance training two to three times a week has strong evidence in supporting cycle regularity, insulin sensitivity and mood. Adequate protein (roughly 1.2–1.6 g/kg body weight for most active women) supports the same. Consistent sleep, particularly the wake-time anchor, supports the circadian-hormonal alignment the cycle depends on.

6.4 Selective supplementation under guidance

Supplements that have reasonable evidence for cycle support, when matched to the underlying issue: magnesium glycinate for PMS and sleep, omega-3s for mood and inflammation, vitamin D where 25-OH is low, B-complex for cycles with significant PMS, and inositol specifically for PCOS-spectrum patterns (under clinical guidance). None of these are universally appropriate, and most are most useful when guided by labs rather than guessed at.

6.5 A baseline cycle panel

A baseline panel at a known cycle phase — day 3 hormones, day 21 progesterone, thyroid, prolactin, ferritin, vitamin D — gives you a structured read on hormonal function that 99% of standard physicals do not include. The two services covered in our comparison page that handle cycle-timed panels most thoughtfully are Function Health (annual subscription, comprehensive) and LetsGetChecked's Women's Health Comprehensive (one-off snapshot, simpler).

When to seek a clinician.

Heme is an editorial layer, not a clinic. The patterns below are worth taking seriously — not as a diagnosis, but as a reason to move the conversation off this page and into a clinical one with someone qualified to see you in context.

Bloodwork is the starting point of this conversation, not the endpoint. Your primary care provider, OB-GYN, women's-health nurse practitioner or reproductive endocrinologist is the right next step once results are in hand. If you're not getting the conversation you need, a second opinion is reasonable — particularly on conditions like endometriosis, PMDD and PCOS, where the average time to diagnosis remains uncomfortably long.